MicroRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis

EMBO Journal

Volumn 34, Issue 3, 2015, Pages 344-360

  De Guia, Roldan M ^a   Rose, Adam J ^a   Sommerfeld, Anke ^a   Seibert, Oksana ^a   Strzoda, Daniela ^a   Zota, Annika ^a   Feuchter, Yvonne ^a   Krones Herzig, Anja ^a   Sijmonsma, Tjeerd ^a   Kirilov, Milen ^a   Sticht, Carsten ^b   Gretz, Norbert ^b   Dallinga Thie, Geesje ^c   Diederichs, Sven ^d,e   Klöting, Nora ^f   Blüher, Matthias ^f   Berriel Diaz, Mauricio ^a   Herzig, Stephan ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

glucocorticoid signalling; LDLR; LSR; miRNA 379; VLDL triglyceride

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LIPID; MICRORNA; MICRORNA 379; MICRORNA 410; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; MIRN379 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DISEASE SEVERITY; ENERGY BALANCE; GENE CLUSTER; GENE INDUCTION; GENE SILENCING; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; HYPERGLUCOCORTICOIDEMIA; INSULIN RESISTANCE; LIPID HOMEOSTASIS; LIVER CELL; MALE; MAMMAL; METABOLIC STRESS; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; UPREGULATION; ANIMAL; CELL LINE; CLINICAL TRIAL; FEMALE; GENETICS; LIPID METABOLISM; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALIA; MAMMALIA; MUS;

ANIMALS; CELL LINE; FEMALE; GENE SILENCING; GLUCOCORTICOIDS; HUMANS; LIPID METABOLISM; LIPOPROTEINS, VLDL; LIVER; MALE; MICE; MICE, OBESE; MICRORNAS; OBESITY; TRIGLYCERIDES;

EID: 84922260813     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.15252/embj.201490464     Document Type: Article

References (60)

1. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP, (2009) Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 94: 2692-2701
2. Bak RO, Hollensen AK, Primo MN, Sorensen CD, Mikkelsen JG, (2013) Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors. RNA 19: 280-293
3. Bartelt A, Bruns OT, Reimer R, Hohenberg H, Ittrich H, Peldschus K, Kaul MG, Tromsdorf UI, Weller H, Waurisch C, Eychmuller A, Gordts PL, Rinninger F, Bruegelmann K, Freund B, Nielsen P, Merkel M, Heeren J, (2011) Brown adipose tissue activity controls triglyceride clearance. Nat Med 17: 200-205
4. Berriel Diaz M, Krones-Herzig A, Metzger D, Ziegler A, Vegiopoulos A, Klingenspor M, Muller-Decker K, Herzig S, (2008) Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice. Hepatology 48: 782-791
5. Canettieri G, Morantte I, Guzman E, Asahara H, Herzig S, Anderson SD, Yates JR 3rd, Montminy M, (2003) Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nat Struct Biol 10: 175-181
6. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP, (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98
7. Foley EM, Gordts PL, Stanford KI, Gonzales JC, Lawrence R, Stoddard N, Esko JD, (2013) Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice. Arterioscler Thromb Vasc Biol 33: 2065-2074
8. Ginsberg HN, (2002) New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 106: 2137-2142
9. Glazov EA, McWilliam S, Barris WC, Dalrymple BP, (2008) Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals. Mol Biol Evol 25: 939-948
10. Grange T, Roux J, Rigaud G, Pictet R, (1989) Two remote glucocorticoid responsive units interact cooperatively to promote glucocorticoid induction of rat tyrosine aminotransferase gene expression. Nucleic Acids Res 17: 8695-8709
11. Grontved L, John S, Baek S, Liu Y, Buckley JR, Vinson C, Aguilera G, Hager GL, (2013) C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. EMBO J 32: 1568-1583
12. Haraguchi T, Ozaki Y, Iba H, (2009) Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 37: e43
13. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J, (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92: 883-893
14. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B, Montminy M, (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413: 179-183
15. Herzig S, Hedrick S, Morantte I, Koo SH, Galimi F, Montminy M, (2003) CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma. Nature 426: 190-193
16. Ishibashi S, Perrey S, Chen Z, Osuga J, Shimada M, Ohashi K, Harada K, Yazaki Y, Yamada N, (1996) Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. J Biol Chem 271: 22422-22427
17. Jones A, Friedrich K, Rohm M, Schafer M, Algire C, Kulozik P, Seibert O, Muller-Decker K, Sijmonsma T, Strzoda D, Sticht C, Gretz N, Dallinga-Thie GM, Leuchs B, Kogl M, Stremmel W, Diaz MB, Herzig S, (2013) TSC22D4 is a molecular output of hepatic wasting metabolism. EMBO Mol Med 5: 294-308
18. Kagami M, Sekita Y, Nishimura G, Irie M, Kato F, Okada M, Yamamori S, Kishimoto H, Nakayama M, Tanaka Y, Matsuoka K, Takahashi T, Noguchi M, Masumoto K, Utsunomiya T, Kouzan H, Komatsu Y, Ohashi H, Kurosawa K, Kosaki K, et al, (2008) Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat Genet 40: 237-242
19. Klingmuller U, Bauer A, Bohl S, Nickel PJ, Breitkopf K, Dooley S, Zellmer S, Kern C, Merfort I, Sparna T, Donauer J, Walz G, Geyer M, Kreutz C, Hermes M, Gotschel F, Hecht A, Walter D, Egger L, Neubert K, et al, (2006) Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage) 153: 433-447
20. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M, Stumvoll M, Bluher M, (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299: E506-E515
21. Kramer W, (2013) Novel drug approaches in development for the treatment of lipid disorders. Exp Clin Endocrinol Diabetes 121: 567-580
22. Kulozik P, Jones A, Mattijssen F, Rose AJ, Reimann A, Strzoda D, Kleinsorg S, Raupp C, Kleinschmidt J, Muller-Decker K, Wahli W, Sticht C, Gretz N, von Loeffelholz C, Stockmann M, Pfeiffer A, Stohr S, Dallinga-Thie GM, Nawroth PP, Berriel Diaz M, et al, (2011) Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia. Cell Metab 13: 389-400
23. Kuo T, Lew MJ, Mayba O, Harris CA, Speed TP, Wang JC, (2012) Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling. Proc Natl Acad Sci USA 109: 11160-11165
24. Labialle S, Marty V, Bortolin-Cavaille ML, Hoareau-Osman M, Pradere JP, Valet P, Martin PG, Cavaille J, (2014) The miR-379/miR-410 cluster at the imprinted Dlk1-Dio3 domain controls neonatal metabolic adaptation. EMBO J 33: 2216-2230
25. Leiter EH, Reifsnyder PC, (2004) Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes. Diabetes 53 (Suppl 1): S4-S11
26. Lemke U, Krones-Herzig A, Berriel Diaz M, Narvekar P, Ziegler A, Vegiopoulos A, Cato AC, Bohl S, Klingmuller U, Screaton RA, Muller-Decker K, Kersten S, Herzig S, (2008) The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. Cell Metab 8: 212-223
27. Lichtenstein L, Berbee JF, van Dijk SJ, van Dijk KW, Bensadoun A, Kema IP, Voshol PJ, Muller M, Rensen PC, Kersten S, (2007) Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol 27: 2420-2427
28. MacArthur JM, Bishop JR, Stanford KI, Wang L, Bensadoun A, Witztum JL, Esko JD, (2007) Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117: 153-164
29. Mahley RW, Huang Y, (2007) Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. J Clin Invest 117: 94-98
30. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M, Kersten S, (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281: 934-944
31. Maniam J, Antoniadis C, Morris MJ, (2014) Early-Life Stress, HPA Axis Adaptation, and Mechanisms Contributing to Later Health Outcomes. Front Endocrinol (Lausanne) 5: 73
32. Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, Raney BJ, Pohl A, Malladi VS, Li CH, Lee BT, Learned K, Kirkup V, Hsu F, Heitner S, Harte RA, et al, (2013) The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 41: D64-D69
33. Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ, Sul HS, (2002) Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 22: 5585-5592
34. Narvekar P, Berriel Diaz M, Krones-Herzig A, Hardeland U, Strzoda D, Stohr S, Frohme M, Herzig S, (2009) Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice. Diabetes 58: 1040-1049
35. Nordestgaard BG, Varbo A, (2014) Triglycerides and cardiovascular disease. Lancet 384: 626-635
36. Opherk C, Tronche F, Kellendonk C, Kohlmuller D, Schulze A, Schmid W, Schutz G, (2004) Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. Mol Endocrinol 18: 1346-1353
37. Phillips DI, Barker DJ, Fall CH, Seckl JR, Whorwood CB, Wood PJ, Walker BR, (1998) Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J Clin Endocrinol Metab 83: 757-760
38. Pirillo A, Norata GD, Catapano AL, (2014) Postprandial lipemia as a cardiometabolic risk factor. Curr Med Res Opin 30: 1489-1503
39. Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, Ray TD, Sheedy FJ, Goedeke L, Liu X, Khatsenko OG, Kaimal V, Lees CJ, Fernandez-Hernando C, Fisher EA, Temel RE, Moore KJ, (2011) Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478: 404-407
40. Redgrave TG, (1973) Cholesterol feeding alters the metabolism of thoracic-duct lymph lipoprotein cholesterol in rabbits but not in rats. Biochem J 136: 109-113
41. Redgrave TG, Roberts DC, West CE, (1975) Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem 65: 42-49
42. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, Schutz G, (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93: 531-541
43. Rohm M, Sommerfeld A, Strzoda D, Jones A, Sijmonsma TP, Rudofsky G, Wolfrum C, Sticht C, Gretz N, Zeyda M, Leitner L, Nawroth PP, Stulnig TM, Diaz MB, Vegiopoulos A, Herzig S, (2013) Transcriptional cofactor TBLR1 controls lipid mobilization in white adipose tissue. Cell Metab 17: 575-585
44. Rose AJ, Vegiopoulos A, Herzig S, (2010) Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations. J Steroid Biochem Mol Biol 122: 10-20
45. Rose AJ, Diaz MB, Reimann A, Klement J, Walcher T, Krones-Herzig A, Strobel O, Werner J, Peters A, Kleyman A, Tuckermann JP, Vegiopoulos A, Herzig S, (2011) Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell Metab 14: 123-130
46. Rose AJ, Herzig S, (2013) Metabolic control through glucocorticoid hormones: an update. Mol Cell Endocrinol 380: 65-78
47. Rottiers V, Naar AM, (2012) MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13: 239-250
48. Sapolsky RM, Meaney MJ, (1986) Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res 396: 64-76
49. Sondergaard E, Sorensen LP, Rahbek I, Gormsen LC, Christiansen JS, Nielsen S, (2012) Postprandial VLDL-triacylglycerol secretion is not suppressed in obese type 2 diabetic men. Diabetologia 55: 2733-2740
50. Spady DK, (1992) Hepatic clearance of plasma low density lipoproteins. Semin Liver Dis 12: 373-385
51. Stefan N, Ramsauer M, Jordan P, Nowotny B, Kantartzis K, Machann J, Hwang JH, Nowotny P, Kahl S, Harreiter J, Hornemann S, Sanyal AJ, Stewart PM, Pfeiffer AF, Kautzky-Willer A, Roden M, Haring HU, Furst-Recktenwald S, (2014) Inhibition of 11beta-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2: 406-416
52. Stenvang J, Petri A, Lindow M, Obad S, Kauppinen S, (2012) Inhibition of microRNA function by antimiR oligonucleotides. Silence 3: 1
53. Vegiopoulos A, Herzig S, (2007) Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol 275: 43-61
54. Wallace C, Smyth DJ, Maisuria-Armer M, Walker NM, Todd JA, Clayton DG, (2010) The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet 42: 68-71
55. Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq C, Yamamoto KR, (2004) Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci USA 101: 15603-15608
56. Wang JC, Gray NE, Kuo T, Harris CA, (2012) Regulation of triglyceride metabolism by glucocorticoid receptor. Cell Biosci 2: 19
57. Watts GF, Ooi EM, Chan DC, (2013) Demystifying the management of hypertriglyceridaemia. Nat Rev Cardiol 10: 648-661
58. Williams KJ, Chen K, (2010) Recent insights into factors affecting remnant lipoprotein uptake. Curr Opin Lipidol 21: 218-228
59. Yen FT, Roitel O, Bonnard L, Notet V, Pratte D, Stenger C, Magueur E, Bihain BE, (2008) Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice. J Biol Chem 283: 25650-25659
60. Yu CY, Mayba O, Lee JV, Tran J, Harris C, Speed TP, Wang JC, (2010) Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis. PLoS One 5: e15188